Request for Applications: U.S.-South Africa Program for Collaborative Biomedical Research – Phase 3 (HIV/AIDS)

The SAMRC is pleased to announce the release of a new funding opportunity by the US National Institutes of Health Research (NIH) under the U.S.-South Africa Program for Collaborative Biomedical Research – Phase 3 (HIV/AIDS). This is a jointly funded program between the SAMRC and the NIH and follows on from the successful Phase 1 and Phase 2 collaborative programs.

The purpose of this Notice of Funding Opportunity (NOFO) is to support research projects under Phase 3 of the U.S.-South Africa Program for Collaborative Biomedical Research.  Research areas supported under this program include HIV/AIDS, HIV/AIDS co-morbidities and co-infections, HIV/AIDS-associated implementation science, and HIV/AIDS-associated data science. The hallmark of the U.S.-South Africa program is the development of collaborative partnerships between South African investigators and United States (U.S.) investigators. Through international collaboration, this research will advance scientific discoveries, promote sharing of technologies and approaches, and serve local public health needs and priorities in support of global HIV/AIDS research.

Please note that, although the NOFO particularly encourages HDIs and universities of technology to apply, the NOFO is open to all NRF eligible entities, i.e. recognized South African public higher education or research institutions such as a universities, universities of technology, science councils, museums or other research institutions as declared by the Department of Science and Innovation.

All applications in response to this RFA are due by 5:00 PM local time of applicant organization on March 12, 2025. Awards will be made around November / December 2025.

For more information on the NOFO and how to apply please use the following link: https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-023.html.